ProQR Therapeutics PRQR 深 滬
等待開盤 09-17 09:30:00 美东时间
1.86
+0.020
+1.09%
華盛通- 最 高1.9017
- 今 開1.85
- 成交量 74.19万股
- 最 低 1.79
- 昨 收 1.84
- 總市值 2.62亿
- 52周最高 3.10
- 市盈率 靜 --
- 換手率 0.53%
- 52周最低 1.33
- 委 比 0.64%
- 總股本 1.41亿
- 歷史最高 27.60
- 量 比 1.10
- 振 幅 6.07%
- 歷史最低 0.53
- 每 手 1
- 風險率 0.36%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多ProQR to Participate in Upcoming Investor Conferences in September 2026
ProQR Therapeutics N.V. announced that its management will participate in the Wells Fargo 21st Annual Healthcare Conference in Boston on September 8 and the 2026 Cantor Global Healthcare Conference in New York on September 9. The company is developing Axiomer™, an RNA base editing technology that uses ADAR to make specific RNA edits, potentially treating diseases caused by RNA mutations. More details are available on ProQR’s website.
09-02 12:00
美股大行评级 | 塔吉特获13家大行上调目标价；Moderna携手默沙东齐获大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Ultragenyx Pharmaceutical"超配"评级，目标价从96美元升至103美元；Canaccord Genuity：维持Ultragenyx Pharmaceutical"买入"评级，目标价从81美元升至83美元
08-21 11:40
ProQR a new buy at BoA on RNA-editing platform
Bank of America Securities has initiated coverage of ProQR Therapeutics (PRQR) at buy, saying that the company's Axiomer RNA-editing platform has been validated, supporting its pipeline. The bank has...
08-20 21:49
B of A Securities Initiates Coverage On ProQR Therapeutics with Buy Rating, Announces Price Target of $8
B of A Securities analyst Alec Stranahan initiates coverage on ProQR Therapeutics (NASDAQ:PRQR) with a Buy rating and announces Price Target of $8.
08-20 20:03
ProQR Therapeutics Q2 EPS $(0.09) Beats $(0.14) Estimate, Sales $10.183M Beat $5.560M Estimate
ProQR Therapeutics (NASDAQ:PRQR) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.14) by 35.71 percent. This is a 25 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $10.183 millio...
08-13 20:12
美股夜盘 | Republic Power涨38.76%，巨龙在线涨22.55%
Tvardi Therapeutics Inc.涨-10.80%；Dreamland涨-9.80%；有信科技涨-9.33%
07-09 08:05
美股大行评级 | 康托·菲茨杰拉德大幅上调AMD、英特尔、迈威尔科技、美光、西部数据目标价！Applied、INIO、LFTO、Quantinuum获多家大行首予买入评级
今日重点评级关注：Evercore ISI集团：维持ProQR Therapeutics"跑赢大市"评级，目标价从5美元升至6美元；摩根士丹利：维持霍尼韦尔"标配"评级，目标价从245美元升至490美元
06-30 10:14
美股大行评级 | 潜在涨幅90.66%！Tango Therapeutics获杰富瑞升目标价至60美元，上调至"买入"评级
今日重点评级关注：杰富瑞：上调Tango Therapeutics评级至"买入"，目标价从27美元升至60美元；Susquehanna：维持安森美半导体"积极"评级，目标价从120美元升至140美元
06-29 15:49
小型生物科技公司ProQR Therapeutics凭借早期试验成功获得礼来投资
普罗科治疗股份有限公司（ProQR Therapeutics N.V.，纳斯达克代码：PRQR）公布在研RNA编辑疗法AX-0810的积极1期临床早期数据，同时...
06-25 22:07
ProQR Therapeutics Prices Registered Direct Offering Of 27,624,310 Shares At $1.81 Per Share For Total Gross Proceeds Of ~$50M; Also Enters Private Placement With Lilly For ~5.1M Shares At Same Offer Price
ProQR Therapeutics N.V. (NASDAQ:PRQR) ("ProQR"), a clinical-stage biotechnology company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced the pricing of an underwritten registered direct offering of 27,...
06-25 18:39
